Merck & Co. forecast 2026 sales and profit that missed Wall Street’s expectations and said its HPV vaccine Gardasil may remain off the market in China this year as it continues to face challenges in ...
There are new concerns about Gardasil, the vaccine that prevents a virus that caused cervical cancer. It's approved for girls as young as nine. And five million have received it since it was approved ...
Gardasil is Merck & Co.’s (MRK) leading vaccine franchise. Gardasil is a vaccine for the prevention of certain strains of HPV (human papillomavirus), a sexually transmitted disease. Total sales of ...
The FDA has approved Gardasil, a vaccine that targets the virus responsible for most cervical cancers and genital warts. Here are 12 questions and answers on the new vaccine. 1. What is Gardasil?
Merck & Co. won’t be able to fully meet global demand for HPV vaccine Gardasil until after 2023 when it completes production of a couple of manufacturing plants. So for now, the drugmaker is again ...
While clicking through Snapchat the other day, an ad for Merck’s new Versed campaign for Gardasil, its vaccine against the human papillomavirus (HPV), stopped my thumb in its tracks. As a researcher ...
Forbes contributors publish independent expert analyses and insights. I offer straight talk on science, medicine, health and vaccines. Jun 22, 2015, 05:40am EDT Aug 16, 2015, 06:03pm EDT This article ...
How long is a drugmaker willing to wait on an indication expansion plan? For Merck’s HPV vaccines, that's 10 years. Merck won the FDA “priority review” designation for an application to expand ...
Merck HPV vaccine Gardasil is poised for major growth by 2025 as new geographies and expanded labels add more people to its patient pool. Although the vaccine is 12 years old, Wolfe Research analysts ...
The US Food and Drug Administration (FDA) today approved Gardasil 9, a human papillomavirus (HPV) vaccine from Merck that prevents cancers and other lesions caused by nine HPV types, five more than ...
The Food and Drug Administration has agreed to expand the use of the popular HPV vaccine Gardasil to prevent anal cancer in young women and men, agency officials said Wednesday. The move approves the ...